New eczema drug shows promise for kids and teens
NCT ID NCT06324812
First seen Jan 04, 2026 · Last updated May 14, 2026 · Updated 23 times
Summary
This study tests a new medicine called 611 in 124 children and teens (ages 6 to 17) with moderate to severe eczema. The goal is to see if it is safe and how well it works to reduce skin symptoms like redness and itching. Participants receive the drug as an injection, and researchers monitor side effects and skin improvement over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERMATITIS, ATOPIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Children's Hospital
Beijing, Beijing Municipality, 100003, China
Conditions
Explore the condition pages connected to this study.